What is Anisophyllea pomifera used for traditionally?

In the Democratic Republic of Congo (Mampa village), Anisophyllea pomifera—locally called lufunga—is the most cited medicinal plant among traditional healers, with 46 recorded citations primarily for urinary infections (fidelity level 0.1563) and secondary uses for gastrointestinal disorders, diabetes, malaria, cough, and hypertension. It functions as a first-line treatment in local ethnomedicine, though preparation methods such as decoction or infusion are not formally documented in peer-reviewed sources. In Tanzania, the fruit is consumed as food and the plant is used to deter rodents from crops.

What antioxidant compounds are found in Anisophyllea pomifera?

The seeds contain the highest total phenolic compounds at 117.09 mg gallic acid equivalents (GAE) per 100 g dry weight, compared to 38.07 mg GAE/100 g in the peel and 25.46 mg GAE/100 g in the pulp. The peel also contains organic acids with antioxidant properties—citric, malic, oxalic, and ascorbic acid—quantified by HPLC. Pomifera oil derived from the fruit demonstrates an EC50 of 5.507% in DPPH radical scavenging, which is superior to rosehip oil's EC50 of 6.190%, indicating potent lipophilic antioxidant compounds.

Is there any clinical evidence supporting Anisophyllea pomifera health claims?

No clinical trials of any design—randomized controlled trials, observational studies, or case series—have been published on Anisophyllea pomifera. Available evidence is limited to in vitro antioxidant assays (DPPH, FRAP), compositional nutritional analyses, and ethnomedicinal citation surveys in DRC communities. This places A. pomifera at a very early, pre-clinical stage of scientific evaluation, and health claims beyond its nutritional food value cannot currently be substantiated by clinical data.

What is the nutritional value of Anisophyllea pomifera fruit?

The fruit pulp contains 19.5% soluble sugars (glucose and fructose) and 1.2% titratable acidity (citric acid equivalent), while seeds are protein-rich at 16.9% dry weight. Seeds also supply significant minerals: potassium (387.2 mg/100 g), phosphorus (267.01 mg/100 g), magnesium (86.01 mg/100 g), calcium (43.8 mg/100 g), and iron (2.3 mg/100 g). Together, these properties support its characterization as a nutrient-dense wild fruit with nutraceutical potential in food-insecure Central African regions.

Is Anisophyllea pomifera (pomifera oil) safe to use?

No formal toxicological or clinical safety data exist for Anisophyllea pomifera in any form, including pomifera oil applied topically or seed/fruit preparations consumed orally. Traditional consumption in DRC and Tanzania has not generated documented adverse effect reports, but this does not establish safety for concentrated supplements or extracts. Individuals with kidney disease should note the oxalic acid content in the peel, and those on potassium-altering medications should be aware of the seeds' high potassium content (387.2 mg/100 g); formal safety studies are needed before supplemental use recommendations can be made.

How does Anisophyllea pomifera oil compare to other plant oils for antioxidant potency?

Anisophyllea pomifera oil demonstrates superior antioxidant capacity compared to rosehip oil, achieving an EC50 of 5.507% versus rosehip's 6.190%, indicating greater free radical neutralization efficiency at lower concentrations. This makes pomifera oil a more potent option for antioxidant support when selecting between commonly used botanical oils. The oil's effectiveness is attributed to its phenolic compounds and capacity for both DPPH free radical scavenging and FRAP reduction.

What is the total phenolic content in Anisophyllea pomifera seeds, and what does this indicate?

Anisophyllea pomifera seeds contain a total phenolic content (TPC) of 117.09 mg gallic acid equivalents per 100g dry weight, which reflects a substantial concentration of polyphenolic antioxidant compounds. This phenolic profile indicates strong antioxidant potential and supports the traditional use of the plant for health purposes in African communities. Higher phenolic content generally correlates with enhanced capacity to neutralize oxidative stress and support cellular health.

Why is Anisophyllea pomifera considered a first-line traditional remedy for gastrointestinal issues in certain African communities?

In DRC Miombo communities, traditional healers prioritize Anisophyllea pomifera as a first-line treatment for gastrointestinal disorders, reflecting generations of ethnobotanical knowledge and observed efficacy in supporting digestive health. This traditional application suggests bioactive compounds within the plant may support gastrointestinal function, though modern clinical validation of this traditional use remains limited. The persistent cultural preference for this remedy indicates consistent positive outcomes in traditional practice, warranting further research into its gastrointestinal mechanisms.

Loengo

Anisophyllea pomifera seeds contain the highest concentration of total phenolic compounds (117.09 mg GAE/100 g DW) among fruit parts, conferring free radical scavenging activity measurable by DPPH and FRAP assays. The derived pomifera oil demonstrates antioxidant potency superior to rosehip oil, achieving an EC50 of 5.507% in DPPH scavenging, suggesting meaningful radical-neutralizing capacity at low concentrations.

Category: African Evidence: 1/10 Tier: Preliminary

Origin & History

Anisophyllea pomifera is a fruit-bearing tree native to the Miombo woodland ecosystems of Central and West Africa, with documented populations in the Democratic Republic of Congo (DRC) and Tanzania. It thrives in the savanna-woodland transition zones characteristic of the Miombo biome, where it grows in well-drained, nutrient-variable soils typical of sub-Saharan Africa. The fruit, known locally as 'loengo' or 'lufunga' in DRC communities, is harvested from wild-growing trees and has not been formally domesticated or commercially cultivated.

Historical & Cultural Context

Anisophyllea pomifera holds the distinction of being the most frequently cited medicinal plant among traditional healers in Mampa village, DRC, with 46 recorded citations, underscoring its central role in local ethnomedicine within the Miombo woodland cultural sphere. It is referred to as 'lufunga' in DRC communities and serves as a first-line treatment for urinary infections, with secondary applications for diabetes, malaria, cough, and hypertension, reflecting a broad-spectrum medicinal reputation consistent with high-phenolic plants across African traditional systems. In Tanzania, the fruit is consumed as a food crop and the plant is reportedly used to deter rodents from agricultural fields, suggesting dual utility as both a nutritional and agroecological resource. The fruit's common name 'loengo' in West/Central African contexts connects it to oral knowledge traditions that have not yet been formally transcribed into structured pharmacopoeial records, leaving preparation methods and dosing wisdom largely outside the peer-reviewed literature.

Health Benefits

- **Antioxidant Activity**: Seed extracts and pomifera oil neutralize free radicals via DPPH scavenging and FRAP reduction, with seed TPC reaching 117.09 mg GAE/100 g DW; the oil achieves an EC50 of 5.507%, outperforming rosehip oil at 6.190%.
- **Gastrointestinal Support**: Traditional healers in DRC Miombo communities use A. pomifera as a first-line treatment for gastrointestinal disorders, supported by 46 citations in ethnomedicinal surveys of Mampa village, though mechanistic data remain uninvestigated.
- **Urinary Tract Health**: Ethnomedicinal records from DRC assign A. pomifera a fidelity level of 0.1563 for urinary infections, making it the most frequently cited plant for this indication among local healers.
- **Nutritional Energy Provision**: Fruit pulp contains 19.5% ± 0.02% soluble sugars (predominantly glucose and fructose), providing readily bioavailable carbohydrate energy consistent with nutraceutical food use in food-insecure regions.
- **Mineral Supplementation**: Seeds supply meaningful quantities of potassium (387.2 mg/100 g), phosphorus (267.01 mg/100 g), and magnesium (86.01 mg/100 g), supporting electrolyte balance, bone metabolism, and enzymatic function.
- **Skin Barrier Protection (Topical)**: Pomifera oil scavenges free radicals that degrade collagen and compromise epidermal barrier integrity at concentrations as low as 4.0% DPPH scavenged, suggesting utility in oxidative-stress-driven skin aging.
- **Glycemic and Metabolic Relevance**: Ethnomedicinal records document 10 citations for diabetes management among Mampa village healers, implying potential glucose-modulating properties that remain entirely uninvestigated at the biochemical level.

How It Works

The primary documented mechanism of A. pomifera is phenolic-mediated free radical scavenging: seed-derived phenolic compounds donate hydrogen atoms or electrons to neutralize DPPH radicals and reduce ferric ions to ferrous ions in FRAP assays, with potency expressed in Trolox equivalents. Pomifera oil maintains antioxidant activity upon dilution, suggesting a dense matrix of lipophilic antioxidant compounds capable of interrupting lipid peroxidation cascades that degrade collagen and membrane phospholipids. Organic acids identified in the peel—citric, malic, oxalic, and ascorbic acid—may contribute secondary antioxidant and chelating activity, with ascorbic acid capable of regenerating oxidized tocopherols in lipid environments. No enzyme inhibition targets, receptor binding data, gene expression modulation, or signal transduction pathway interactions have been characterized for any fraction of A. pomifera in published literature.

Scientific Research

Available scientific evidence for A. pomifera is confined to in vitro nutritional characterization studies and ethnomedicinal field surveys, representing a very early and limited evidence base. Compositional analyses have quantified phenolic content, antioxidant activity (DPPH, FRAP), proximate composition, organic acids (via HPLC with high analytical precision, R²=0.9994 for citric acid), and mineral profiles across seed, peel, and pulp fractions of the fruit. Ethnomedicinal surveys conducted in the DRC (Mampa village) systematically documented traditional use citations and fidelity levels, providing structured qualitative data but no mechanistic or clinical outcomes. No animal studies, preclinical pharmacological models, pharmacokinetic investigations, or human trials of any design have been published; the evidence base does not yet support conclusions about efficacy, optimal dose, or safety in supplemental contexts.

Clinical Summary

No clinical trials have been conducted on Anisophyllea pomifera in any form—neither as a whole fruit, extract, seed preparation, nor pomifera oil administered orally or topically in a controlled human study. The totality of human-relevant evidence consists of cross-sectional ethnomedicinal surveys documenting traditional healer citation frequencies and fidelity levels for conditions including gastrointestinal disorders, urinary infections, diabetes, malaria, cough, and hypertension in DRC communities. Outcome measures, effect sizes, confidence intervals, and comparative efficacy data are entirely absent from the published record. Confidence in any clinical claim is therefore very low, and A. pomifera must currently be classified as a candidate ingredient requiring foundational preclinical and eventual clinical investigation before supplemental health claims can be substantiated.

Nutritional Profile

Pulp proximate: soluble sugars 19.5% ± 0.02% DW (glucose and fructose as primary fractions); titratable acidity 1.2% ± 0.1% DW (citric acid equivalent). Seed proximate: protein 16.9% ± 0.2% DW (highest among fruit parts); seeds are the nutritionally densest fraction. Seed minerals (mg/100 g DW): potassium 387.2, phosphorus 267.01, magnesium 86.01, calcium 43.8, iron 2.3. Phytochemicals: total phenolic compounds by part—seeds 117.09 mg GAE/100 g DW, peel 38.07 mg GAE/100 g DW, pulp 25.46 mg GAE/100 g DW. Peel organic acids: citric, malic, oxalic, and ascorbic acids (quantified by HPLC). Antioxidant activity strongest in seeds (DPPH and FRAP expressed in mg Trolox/100 g DW; specific values not fully disclosed in available sources). Bioavailability of phenolics from seeds may be influenced by the seed's protein-phenol binding matrix, but no human absorption data exist.

Preparation & Dosage

- **Traditional Whole Fruit (Oral)**: Consumed fresh as food in Tanzania and DRC; no quantified dose established; presumed ad libitum consumption as part of local diet.
- **Traditional Medicinal Preparation (Decoction/Infusion)**: Inferred from ethnomedicinal context in DRC Miombo communities; healers administer preparations for gastrointestinal disorders and urinary infections; specific parts used, preparation ratios, and dosing frequency are undocumented in peer-reviewed sources.
- **Pomifera Oil (Topical)**: Applied to skin for antioxidant and barrier-protective purposes; no standardized concentration or application frequency established; effective antioxidant activity observed at EC50 of 5.507% in DPPH assay.
- **Seed Powder/Extract (Experimental/Nutraceutical)**: Seeds contain the highest TPC (117.09 mg GAE/100 g DW) and protein (16.9% ± 0.2%); no standardized extract percentage, capsule dose, or clinical dose range has been established.
- **Standardization**: No commercial standardization to phenolic content, antioxidant activity, or any marker compound has been published or validated.

Synergy & Pairings

No experimentally validated synergistic combinations involving Anisophyllea pomifera have been reported in the scientific literature. Theoretically, the ascorbic acid content in the peel may act synergistically with the lipophilic antioxidants in pomifera oil by regenerating oxidized radical-scavenging intermediates, a mechanism well-established for vitamin C and plant polyphenol combinations in other species. The seed's mineral profile (particularly magnesium and potassium) could complement electrolyte-supporting formulations, but no pharmacological stacking data or co-administration studies exist to validate any specific pairing.

Safety & Interactions

No formal toxicological studies, adverse event monitoring, or safety pharmacology data have been conducted on any preparation of Anisophyllea pomifera, representing a critical gap that prevents evidence-based safety characterization. The fruit has been consumed traditionally in DRC and Tanzanian communities without reported adverse effects noted in ethnomedicinal literature, which provides weak reassurance of tolerability at food-level consumption but does not address concentrated extract or supplemental dose safety. No drug interaction data exist; the presence of oxalic acid in the peel warrants theoretical caution in individuals prone to oxalate nephrolithiasis or those with renal insufficiency, and the high potassium content in seeds (387.2 mg/100 g) is a consideration for patients on potassium-sparing diuretics or ACE inhibitors. Pregnancy and lactation safety, pediatric dosing, maximum tolerated doses, and contraindications are entirely undefined; use beyond traditional food consumption should be approached with caution until toxicological studies are completed.